Research in our laboratory focusses on two major pillars:

  • understanding the pathophysiological mechanisms causing neurodegenerative disorders like Parkinson´s and Alzheimer´s disease. Special attention is paid to proteins of the synuclein family, since a-synuclein is a major component of aggregate structures in both diseases.

  • development of adeno-associated viral vector (AAV) technology, enabling us to express any kind of protein or regulatory RNA in cells refractory to conventional gene transfer methods both in vitro and in vivo. AAV vectors are also used for establishment of pre-clinical gene therapy protocols for treatment of Parkinson´s disease and other CNS disorders.

  • Vector tech and general applications

  • Gene therapy 1: MoCo deficiency

  • Gene therapy 2: Pharmacological control of therapeutic transgene expression

  • Gene therapy 3: Dual AAV for large transgenes: treatment of deafness

  • Synuclein research 1: pathophysiological effects on mitochondrial integrity

  • Synuclein research 2: pathophysiological effects on neuronal network activity

Dr. Sebastian Kügler
Principal Investigator